Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers
Colon-Otero, Gerardo, Zanfagnin, Valentina, Hou, Xiaonan, Foster, Nathan R, Asmus, Erik J, Wahner Hendrickson, Andrea, Jatoi, Aminah, Block, Matthew S, Langstraat, Carrie L, Glaser, Gretchen E, Dinh,Volume:
5
Journal:
ESMO Open
DOI:
10.1136/esmoopen-2020-000926
Date:
October, 2020
File:
PDF, 1.22 MB
2020